AbbVie, Investors Reach $17M Deal Over Failed Inversion
By Amy Lee Rosen · June 19, 2019, 8:20 PM EDT
Drugmaker AbbVie Inc. has reached a $16.75 million agreement to settle a claim that it misled investors about the risks of its failed $54 billion merger with Irish pharmaceutical company Shire...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login